Neurologiczny NZOZ Centrum Leczenia SM Ośrodek Badań Klinicznych im. dr n. med. Hanki Hertmanowskiej
- Address
- Ul. Czerwińskiego 8, 40-123 Katowice, Poland
Neurologiczny NZOZ Centrum Leczenia SM - Parkinson's Disease Research Center
The Neurologiczny NZOZ Centrum Leczenia SM Ośrodek Badań Klinicznych, named in honor of dr n. med. Hanka Hertmanowska, is a specialized neurological research center dedicated to advancing therapeutic options for patients with movement disorders. The center has established expertise in conducting clinical trials focused on Parkinson's disease, with particular emphasis on both symptomatic management and disease-modifying interventions.
- Novel pharmacological approaches for Parkinson's disease tremor management
- Genetically-targeted therapies for LRRK2-driven Parkinson's disease
- Early-stage Parkinson's disease treatment strategies
The center's research portfolio includes evaluation of innovative compounds such as suvecaltamide for tremor control and NEU-411 for LRRK2-associated Parkinson's disease, demonstrating commitment to both symptom relief and precision medicine approaches. This dual focus on functional improvement and companion diagnostic-guided interventions positions the center at the forefront of personalized neurological care and clinical research in movement disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Neuron23 Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Neurologiczny NZOZ Centrum Leczenia SM Ośrodek Badań Klinicznych im. dr n. med. Hanki Hertmanowskiej
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Suvecaltamide in Treating Moderate to Severe Residual Tremor in Parkinson's Disease: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study | Cavion Inc. | Phase II | Not Recruiting | Jun 2023 | Nov 2024 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Suvecaltamide | 1 | Unknown | 2023-06-21 | 2023-06-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.